Overview
Pain management therapeutics is a branch of medicine focused on the treatment of chronic pain. The field uses a multidisciplinary approach to reduce suffering and improve the quality of life for people with chronic pain. Also known as algiatry, this field is a great help to people with various kinds of illnesses. It is the branch of medicine that focuses on chronic pain, and it is a vital component of many other fields. It is the only field that combines all disciplines to manage pain. The pharmaceutical industry has also invested in new drugs, and this is helping companies expand their business.
Request Free Sample Copy With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/4626
Competitive Landscape
Major companies contributing to the global pain management therapeutics market include Covidien Plc., Allergan, Inc., Abbott Laboratories, Forest Laboratories, Inc., McKesson Corporation, Teva Pharmaceuticals, AmerisourceBergen, Cardinal Health, Merck & Co., Inc., AcelRx Pharmaceuticals, Inc. Novartis International AG, Averitas Pharma, Inc., Mundipharma International Ltd., Hospira, Inc., Johnson & Johnson, GlaxoSmithKline Plc., Endo Health Solutions, Eli Lilly and Company, and Durect Corporation.
Drivers
The burgeoning caseload of chronic diseases in parallel to the growing senescent population is expected to propel the growth of the pain management therapeutics market over the forecast period.
Moreover, the advent of novel drug delivery methods amidst an accelerated approval pathway for newer therapeutics is expected to aid the growth of the pain management therapeutics market during the forecast period.
Summary of the COVID-19 Aftermath
The onset of the COVID-19 debacle has made a detrimental impact on the global pain management therapeutics market. In the light of the risk of virus transmission, patients preferred virtual consultations in lieu of in-person appointments, thus, reducing footfalls at the surgical centers.
Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4626
Table of Content
Key Takeaways
The pain management therapeutics market is anticipated to grow at a CAGR of 3.6 % during the forecast period owing to the increasing initiatives from governments to reduce reliance on traditional refrigerants. For instance, in November 2021, the U.S. Food and Drug Administration (FDA) approved EaseVRx Therapy, which uses VR-based solutions to manage chronic back pain.
Considering the territorial landscape, the North American region is cementing itself as a reckoning force in the global pain management therapeutics market on the heels of increasing therapeutic approvals, accelerated R&D activities, and a high prevalence of chronic disorders.
Also standing out in the global pain management therapeutics market is the Asia Pacific region, which is driven by increasing awareness over early detection of chronic diseases, increasing support from government, and growing medical tourism.
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Pain Type
- Market Snippet, By Drug Class
- Market Snippet, By Indication
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- Regulatory Scenario
- PEST Analysis
- Mergers and Acquisitions
- Market Dynamics
- Global Pain Management Therapeutics Market, By Pain Type, 2020 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Chronic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Acute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Introduction
- Global Pain Management Therapeutics Market, By Drug Class, 2020 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- NSAIDS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Anticonvulsant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Anti-migraine Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Antidepressant Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Non-narcotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Introduction
- Global Pain Management Therapeutics Market, By Indication, 2020 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Arthritic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Neuropathic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Cancer Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Chronic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Post-operative Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Migraine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Fibromyalgia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Bone Fracture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Muscle Sprain/Strain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Acute Appendicitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
- Introduction
- Global Pain Management Therapeutics Market, By Region, 2020 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018–2028
- North America
- Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- AcelRx Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Averitas Pharma, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AmerisourceBergen
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cardinal Health
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- McKesson Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teva Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Allergan, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Covidien plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Durect Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Endo Health Solutions, Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Forest Laboratories, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hospira, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mundipharma International Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AcelRx Pharmaceuticals, Inc.
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/4626
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com